NET
7 drugs CNSPain
4
approved indications
7
Approved Drugs
7
Companies
9
Indications
2
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (7 companies)
✓ All 7 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (9 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
MEDICAP LABS 1 drug
UPJOHN 1 drug
COLLEGIUM PHARM INC 1 drug
By Therapeutic Area
CNS 5 drugs
Pain 1 drugs
Drugs by Company PRO
MEDICAP LABS 1 drug
UPJOHN 1 drug
COLLEGIUM PHARM INC 1 drug
AXSOME MALTA 1 drug
PF PRISM CV 1 drug
AbbVie 1 drug
PRINSTON INC 1 drug
By Therapeutic Area
CNS 5 drugs
VENLAFAXINE HYDROCHLORIDE, EFFEXOR XR, PRISTIQ, FETZIMA +1 more
Pain 1 drugs
NUCYNTA ER
Other 1 drugs
SUNOSI
Indications Treated
Major Depressive DisorderGeneralized Anxiety DisorderSocial Anxiety DisorderPanic DisorderNarcolepsyObstructive Sleep ApneaPainNeuropathic PainDiabetic Neuropathy
All Drugs Targeting NET
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| VENLAFAXINE HYDROCHLORIDE | MEDICAP LABS | 2006 | 4 | CNS |
| EFFEXOR XR | UPJOHN | 1997 | 4 | CNS |
| NUCYNTA ER | COLLEGIUM PHARM INC | 2011 | 3 | Pain |
| SUNOSI | AXSOME MALTA | 2019 | 2 | |
| PRISTIQ | PF PRISM CV | 2008 | 1 | CNS |
| FETZIMA | AbbVie | 2013 | 1 | CNS |
| LEVOMILNACIPRAN HYDROCHLORIDE | PRINSTON INC | 2019 | 1 | CNS |